Preeti Sudheendra: Lifestyle Medicine as a Core in Breast Cancer Survivorship Care

Preeti Sudheendra, Clinical Director of Late Phase Breast Cancer Drug Development at Merck, shared on LinkedIn a few current paper by Laura E Wright printed on The Oncologist:

“We are formally in print! Check out this assessment article in The Oncologist Journal with complete, evidence-based details about the advantages of life-style medication counseling and interventions for breast most cancers survivors to enhance high quality of life in addition to cut back cancer-related morbidity and mortality.

Lifestyle modification isn’t simple or fast or a single occasion. It doesn’t come as a tablet or injection or process. It is the onerous each day work of taking intentional actions to enhance our bodily, psychological, and emotional well-being. But the funding is well worth the repay.

Lifestyle medication implementation isn’t simple or fast both – it takes time and sources with no fast financial revenue. But it should be achieved. We are doing a disservice to ourselves, our sufferers, our clinics, and our healthcare system by not mandating that life-style medication be a core a part of each Survivorship clinic and past.”

Title: Evidence for the advantages of life-style medication interventions in breast most cancers survivorship

Authors: Laura E Wright , Preeti Sudheendra

Read the complete article.

More posts that includes Breast Cancer.